glucose, (beta-d)-isomer has been researched along with carbonates in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 13 (65.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arziani, B; Kvesitadze, G; Mithaishvili, T; Phiriashvili, V; Ugrekhelidze, D | 1 |
| Anai, M; Arakawa, K; Asano, T; Endou, H; Ishihara, T; Kanai, Y; Kuronuma, Y; Matsumoto, M; Nawano, M; Oku, A; Saito, A; Tsujihara, K; Ueta, K | 1 |
| Anai, M; Arakawa, K; Asano, T; Funaki, M; Kikuchi, M; Nawano, M; Oka, Y; Oku, A; Saito, A; Ueta, K | 1 |
| Anai, M; Arakawa, K; Asano, T; Ishirahara, T; Kikuchi, M; Nawano, M; Oku, A; Saito, A; Ueta, K; Umebayashi, I | 1 |
| Anai, M; Arakawa, K; Asano, T; Kano-Ishihara, T; Matsumoto, M; Nawano, M; Oku, A; Saito, A; Tsujihara, K; Ueta, K | 1 |
| Adachi, T; Iwakura, I; Kitamura, K; Okamoto, Y; Oku, A; Saito, A; Seino, Y; Shihara, N; Tsuda, K; Ueta, K; Yamada, Y; Yano, H; Yasuda, K | 1 |
| Adachi, T; Arakawa, K; Ikezawa, K; Kano-Ishihara, T; Matsumoto, T; Oku, A; Saito, A; Tsuda, K; Ueta, K; Yasuda, K | 1 |
| Adachi, T; Arakawa, K; Kano-Ishihara, T; Matsumoto, M; Oku, A; Saito, A; Tsuda, K; Ueta, K; Yasuda, K | 1 |
| Arakawa, K; Ishihara, T; Kitamura, K; Matsumoto, M; Nawano, M; Oku, A; Saito, A; Ueta, K | 1 |
| Adachi, T; Fujimoto, S; Mukai, E; Nunoi, K; Okamoto, Y; Oku, A; Seino, Y; Shihara, N; Suzuki, N; Tamon, A; Tsuda, K; Yasuda, K | 1 |
| Saito, A; Seiyaku, T; Tsujihara, K | 1 |
| Arakawa, K; Fujita, T; Ishihara, T; Matsumoto, Y; Nawano, M; Oku, A; Saito, A; Ueta, K | 1 |
| Crich, D; Jayalath, P | 1 |
| Arakawa, K; Nishiyama, S; Oku, A; Saito, A; Ueta, K; Yoneda, H | 1 |
| Donahue, EP; Fujimoto, Y; Shiota, M; Torres, TP | 1 |
| Isaji, M | 1 |
| Bisping, E; Gasser, R; Grimm, M; Haas, T; Huber, MS; Pieske, B; Rainer, PP; Roessl, U; von Lewinski, D; Wasler, A; Wilhelm, B | 1 |
| Hongu, M; Kawanishi, E; Kimata, H; Koga, Y; Nakayama, K; Nomura, S; Sakamaki, S; Sakamoto, T; Tsuda-Tsukimoto, M; Ueta, K; Yamamoto, Y | 1 |
| Miyamoto, L; Tsuchiya, K | 1 |
| Connelly, KA; Desjardins, JF; Gilbert, RE; Thai, K; Zhang, Y | 1 |
3 review(s) available for glucose, (beta-d)-isomer and carbonates
| Article | Year |
|---|---|
[SGLT inhibitor (T-1095)].
Topics: Animals; Carbonates; Diabetes Mellitus; Disease Models, Animal; Drug Design; Energy Metabolism; Glucose; Glucosides; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Kidney; Monosaccharide Transport Proteins | 2002 |
Sodium-glucose cotransporter inhibitors for diabetes.
Topics: Animals; Carbonates; Clinical Trials, Phase II as Topic; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Molecular Structure; Sodium-Glucose Transport Proteins | 2007 |
[Sodium-Glucose Transporters as a Therapeutic Target for Diabetes from the Viewpoint of Drug Discovery and Pharmacotherapy].
Topics: Body Weight; Carbonates; Diabetes Mellitus; Drug Discovery; Energy Metabolism; Glucosides; Humans; Hypoglycemic Agents; Molecular Targeted Therapy; Phloretin; Phlorhizin; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2018 |
17 other study(ies) available for glucose, (beta-d)-isomer and carbonates
| Article | Year |
|---|---|
Detoxication of phenol in annual plant seedlings.
Topics: Amino Acids; Biodegradation, Environmental; Carbonates; Environmental Pollutants; Fabaceae; Glucosides; Molecular Weight; Oligosaccharides; Peptides; Phenol; Plants; Plants, Medicinal; Triticum | 1999 |
T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.
Topics: Administration, Oral; Animals; Carbonates; Diabetes Mellitus, Experimental; Dogs; Glucose; Glucosides; Humans; Kidney; Male; Mice; Monosaccharide Transport Proteins; Postprandial Period; Rats; Rats, Sprague-Dawley; Sodium; Xenopus | 1999 |
Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/PKB activations in ZDF rat liver.
Topics: Animals; Blood Glucose; Body Weight; Carbonates; Dose-Response Relationship, Drug; Enzyme Activation; Glucosides; Hyperglycemia; Insulin; Insulin Receptor Substrate Proteins; Intracellular Signaling Peptides and Proteins; Liver; Membrane Glycoproteins; Monosaccharide Transport Proteins; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Receptor, Insulin; Signal Transduction; Sodium-Glucose Transporter 1; Time Factors | 1999 |
Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; Carbonates; Diabetes Mellitus; Glucokinase; Glucose Transporter Type 4; Glucose-6-Phosphatase; Glucosides; Hyperglycemia; Hyperinsulinism; Insulin Resistance; Liver; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Obesity; Rats; Rats, Zucker | 2000 |
Antidiabetic effect of T-1095, an inhibitor of Na(+)-glucose cotransporter, in neonatally streptozotocin-treated rats.
Topics: Animals; Animals, Newborn; Blood Glucose; Carbonates; Diabetes Mellitus, Experimental; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Glucose Transporter Type 1; Glucose Transporter Type 4; Glucosides; Glycosuria; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Microvilli; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Sodium | 2000 |
T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Body Weight; Carbonates; Diabetes Mellitus, Experimental; Glucose Transporter Type 2; Glucosides; Glycated Hemoglobin; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Jejunum; Kidney; Male; Monosaccharide Transport Proteins; Organ Size; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Urine | 2000 |
Correction of hyperglycemia and insulin sensitivity by T-1095, an inhibitor of renal Na+-glucose cotransporters, in streptozotocin-induced diabetic rats.
Topics: Animals; Carbonates; Deoxyglucose; Diabetes Mellitus, Experimental; Glucosides; Hyperglycemia; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Lactic Acid; Male; Monosaccharide Transport Proteins; Muscle, Skeletal; Rats | 2000 |
Antihyperglycemic effect of T-1095 via inhibition of renal Na+-glucose cotransporters in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Carbonates; Diabetes Mellitus, Experimental; Glucosides; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Kidney; Male; Microvilli; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2000 |
Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.
Topics: Animals; Blood Glucose; Carbonates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucagon; Glucose Tolerance Test; Glucosides; Glycosuria; Hypoglycemic Agents; Insulin; Kidney Glomerulus; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Obese; Microvilli; Monosaccharide Transport Proteins; Pancreas; Phenotype; Sodium-Glucose Transporter 1 | 2001 |
Normalization of cytoplasmic calcium response in pancreatic beta-cells of spontaneously diabetic GK rat by the treatment with T-1095, a specific inhibitor of renal Na+-glucose co-transporters.
Topics: Animals; Arginine; Blood Glucose; Calcium; Carbonates; Diabetes Mellitus, Type 2; Glucosides; Glycated Hemoglobin; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Monosaccharide Transport Proteins; Rats; Rats, Wistar | 2002 |
Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
Topics: Administration, Oral; Animals; Carbonates; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diet; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose; Glucose Tolerance Test; Glucosides; Hyperglycemia; Insulin Resistance; Male; Membrane Glycoproteins; Monosaccharide Transport Proteins; Rats; Rats, Inbred Strains; Rats, Wistar; Sodium; Sodium-Glucose Transporter 1; Time Factors | 2005 |
Stereocontrolled formation of beta-glucosides and related linkages in the absence of neighboring group participation: influence of a trans-fused 2,3-O-carbonate group.
Topics: Carbonates; Glucosides; Molecular Conformation | 2005 |
Reduction of renal transport maximum for glucose by inhibition of NA(+)-glucose cotransporter suppresses blood glucose elevation in dogs.
Topics: Animals; Blood Glucose; Carbonates; Dogs; Dose-Response Relationship, Drug; Female; Glucose; Glucose Tolerance Test; Glucosides; Hyperglycemia; Kidney; Male; Postprandial Period; Sodium; Sodium-Glucose Transport Proteins | 2006 |
Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Carbonates; Carrier Proteins; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Glucokinase; Glucose; Glucose-6-Phosphatase; Glucosides; Glycogen; Glycogen Synthase; Hyperglycemia; Insulin; Liver; Liver Glycogen; Male; Muscle, Skeletal; Phosphorylases; Rats; Rats, Zucker | 2006 |
Functional effects of glucose transporters in human ventricular myocardium.
Topics: Aged; Carbonates; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Glucose Transporter Type 1; Glucose Transporter Type 4; Glucosides; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Inhibitory Concentration 50; Insulin; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Phosphoinositide-3 Kinase Inhibitors; RNA, Messenger; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2010 |
Discovery of canagliflozin, a novel C-glucoside with thiophene ring, as sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Topics: Animals; Biological Availability; Canagliflozin; Carbonates; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Male; Mice; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Stereoisomerism; Structure-Activity Relationship; Thiophenes | 2010 |
Dual inhibition of sodium-glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction.
Topics: Animals; Benzhydryl Compounds; Carbonates; Disease Models, Animal; Glucosides; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardium; Rats, Inbred F344; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2018 |